Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since.
With high healthcare costs, bills can quickly add up. In some cases, it is possible to negotiate your medical bills. Barak Richman, law professor at George Washington University, joined Cheddar News to discuss the easiest way to talk to medical debt companies about what's owed.
Millions of people have selected insurance plans for 2024 but sometimes navigating them can be tricky time consuming and expensive. Paula Pant, host of 'Afford Anything' podcast, joined Cheddar News to break down what's needed to know about their insurance plans.
A new study is shedding light on the benefits of the fast-mimicking diet and heart health.
A study published in the journal E-Clinical Medicine suggests there may be a link between air pollution and an increased risk of dementia and strokes.
A new pill is now available to treat postpartum depression.
Prescribed burn associations are proving key to conservationists’ efforts to restore a longleaf pine range forming the backbone of forest ecology in the American Southeast.
A new study suggests higher blood sugar levels after eating could be a good thing.
The Centers for Disease Control and Prevention announced an urgent need to increase vaccination coverage in response to rising respiratory disease levels.
The World Health Organization has warned that all E-cigarettes should be treated like tobacco and all flavored vapes should be banned.
Merck and Moderna's cancer vaccine reduces the risk of death by about half, according to mid-stage trial data released Thursday.
